Get the Stockscreener App
205.07
0.56%
-1.16
Overview
News
Price History
Option Chain
Financials
Why ABBV Down?
Discussions
Forecast
Dividend History
Abbvie Inc stock is traded at $205.07, with a volume of 27.97M.
It is down -0.56% in the last 24 hours and down -8.78% over the past month.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
See More
Previous Close:
$206.23
Open:
$206.265
24h Volume:
27.97M
Relative Volume:
3.99
Market Cap:
$362.60B
Revenue:
$61.16B
Net Income/Loss:
$4.19B
P/E Ratio:
86.84
EPS:
2.3614
Net Cash Flow:
$17.82B
1W Performance:
-6.65%
1M Performance:
-8.78%
6M Performance:
-7.82%
1Y Performance:
-3.25%
1-Day Range:
$203.06
$207.78
1-Week Range:
$203.06
$224.37
52-Week Range:
$164.39
$244.81
Abbvie Inc Stock (ABBV) Company Profile
Name
Abbvie Inc
Sector
Industry
Phone
(847) 932-7900
Address
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Compare ABBV vs LLY, JNJ, AZN, MRK
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
205.07 | 362.60B | 61.16B | 4.19B | 17.82B | 2.3614 |
LLY
Lilly Eli Co
|
906.70 | 809.68B | 65.18B | 20.64B | 5.96B | 22.59 |
JNJ
Johnson Johnson
|
235.37 | 566.92B | 94.19B | 26.80B | 19.70B | 11.05 |
AZN
Astrazeneca Plc
|
183.60 | 284.73B | 58.80B | 10.24B | 8.98B | 3.2788 |
MRK
Merck Co Inc
|
114.18 | 282.30B | 64.93B | 18.26B | 12.36B | 7.2751 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-25-26 | Initiated | RBC Capital Mkts | Outperform |
| Feb-20-26 | Initiated | Barclays | Overweight |
| Jan-08-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-07-26 | Resumed | UBS | Neutral |
| Dec-10-25 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-13-25 | Initiated | Scotiabank | Sector Outperform |
| Nov-04-25 | Downgrade | DZ Bank | Buy → Hold |
| Oct-14-25 | Downgrade | Erste Group | Buy → Hold |
| Oct-01-25 | Downgrade | HSBC Securities | Buy → Hold |
| Sep-17-25 | Upgrade | Berenberg | Hold → Buy |
| Aug-12-25 | Resumed | Piper Sandler | Overweight |
| Aug-07-25 | Upgrade | Daiwa Securities | Neutral → Outperform |
| May-14-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-22-25 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-10-24 | Resumed | BofA Securities | Neutral |
| Dec-05-24 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Nov-22-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Nov-04-24 | Upgrade | Argus | Hold → Buy |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Jun-05-24 | Upgrade | HSBC Securities | Hold → Buy |
| May-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-29-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-18-23 | Downgrade | HSBC Securities | Buy → Hold |
| Dec-11-23 | Upgrade | Goldman | Neutral → Buy |
| Nov-09-23 | Initiated | Deutsche Bank | Hold |
| Oct-30-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-20-23 | Resumed | UBS | Neutral |
| Sep-29-23 | Initiated | Raymond James | Outperform |
| Jul-25-23 | Initiated | William Blair | Mkt Perform |
| Jul-14-23 | Initiated | HSBC Securities | Buy |
| Apr-05-23 | Downgrade | Argus | Buy → Hold |
| Mar-01-23 | Initiated | Guggenheim | Buy |
| Feb-22-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-10-23 | Upgrade | SVB Securities | Underperform → Market Perform |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Nov-08-22 | Downgrade | Societe Generale | Buy → Hold |
| Aug-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-23-22 | Initiated | SVB Leerink | Underperform |
| May-06-22 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Apr-06-22 | Resumed | Morgan Stanley | Overweight |
| Feb-28-22 | Downgrade | UBS | Buy → Neutral |
| Feb-03-22 | Reiterated | BMO Capital Markets | Outperform |
| Feb-03-22 | Reiterated | Barclays | Equal Weight |
| Feb-03-22 | Reiterated | BofA Securities | Neutral |
| Feb-03-22 | Reiterated | Goldman | Neutral |
| Jan-13-22 | Initiated | Redburn | Buy |
| Jan-12-22 | Reiterated | BMO Capital Markets | Outperform |
| Dec-09-21 | Resumed | Wells Fargo | Overweight |
| Nov-23-21 | Upgrade | Societe Generale | Hold → Buy |
| Jul-27-21 | Resumed | Truist | Buy |
| Apr-07-21 | Resumed | RBC Capital Mkts | Outperform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Jun-23-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jun-09-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Upgrade | Argus | Hold → Buy |
| May-18-20 | Resumed | BofA/Merrill | Neutral |
| May-12-20 | Upgrade | JP Morgan | Neutral → Overweight |
| May-11-20 | Resumed | Morgan Stanley | Overweight |
| Apr-20-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Mar-23-20 | Downgrade | Societe Generale | Buy → Hold |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Feb-06-20 | Initiated | Mizuho | Buy |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-26-19 | Reiterated | Cowen | Outperform |
| Sep-26-19 | Upgrade | Citigroup | Neutral → Buy |
| Aug-20-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jun-27-19 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-26-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-28-19 | Initiated | Goldman | Neutral |
| Apr-29-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
View All
Abbvie Inc Stock (ABBV) Latest News
AbbVie Stock Slides as Insider Selling Spooks Investors - TipRanks
AbbVie Inc. $ABBV Shares Sold by TruWealth Advisors LLC - MarketBeat
Neville Rodie & Shaw Inc. Has $23.31 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Is AbbVie Inc. (ABBV) one of the debt free halal stocks to buy? - MSN
If You Invested $1,000 in Abbvie Inc (ABBV) - Stock Titan
The Smartest Dividend ETF to Buy With $1,000 Right Now - The Motley Fool
Union Bancaire Privee UBP SA Boosts Stake in AbbVie Inc. $ABBV - MarketBeat
Park National Corp OH Sells 10,959 Shares of AbbVie Inc. $ABBV - MarketBeat
Hudson Bay Capital Management LP Buys 13,466 Shares of AbbVie Inc. $ABBV - MarketBeat
Coastline Trust Co Buys 10,492 Shares of AbbVie Inc. $ABBV - MarketBeat
Farmers National Bank Increases Stake in AbbVie Inc. $ABBV - MarketBeat
Alecta Tjanstepension Omsesidigt Buys 110,300 Shares of AbbVie Inc. $ABBV - MarketBeat
AIA Group Ltd Purchases 15,295 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie, Alloy Therapeutics Ink Deal to Develop Next-Gen Antibody Platform - Yahoo Finance
AbbVie (ABBV) looks to deepen its push into rapidly growing obesity-treatment market - MSN
Atopic Dermatitis Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | GlaxoSmithKline PLC, Nestle SA, Pfizer Inc., Regeneron Pharma, Abbvie - Barchart
AbbVie (ABBV) Declines More Than Market: Some Information for Investors - Yahoo Finance
AbbVie Inc. stock underperforms Thursday when compared to competitors - MarketWatch
AbbVie Inc (ABBV) Stock Price, Trades & News - GuruFocus
Buy Or Fear AbbVie Stock At $210? - Forbes
What’s Happening With AbbVie Stock? - Trefis
Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie - Benzinga
United Therapeutics or AbbVie: Which Stock Has More Upside? - Trefis
Stillwater Wealth Management Group Takes Position in AbbVie Inc. $ABBV - MarketBeat
Groupama Asset Managment Purchases 10,854 Shares of AbbVie Inc. $ABBV - MarketBeat
Investment Research Partners LLC Buys New Shares in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by CIBC Private Wealth Group LLC - MarketBeat
243,718 Shares in AbbVie Inc. $ABBV Bought by CIBC Bancorp USA Inc. - MarketBeat
Centaurus Financial Inc. Has $3.08 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Allworth Financial LP Acquires 30,124 Shares of AbbVie Inc. $ABBV - MarketBeat
Achmea Investment Management B.V. Has $84.36 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. Stock (ISIN: US00287Y1091) Faces Pressure Amid Recent Pullback: Key Drivers and Investor - AD HOC NEWS
Assessing AbbVie (ABBV) Valuation After The Recent Share Price Pullback - Yahoo Finance
What's Going On With AbbVie Stock Today?AbbVie (NYSE:ABBV) - Benzinga
AbbVie Inc. stock underperforms Wednesday when compared to competitors - MSN
AbbVie (NYSE:ABBV) Trading Down 5.1%Here's Why - MarketBeat
AbbVie (ABBV) Stock Drops 5% After FDA Approves J&J’s Competing Psoriasis Drug - CoinCentral
AbbVie (ABBV) Faces New Competition from J&J's Icotyde Approval - GuruFocus
AbbVie Inc. (ABBV) is attracting investor attention: Here is what you should know - MSN
J&J’s new psoriasis pill to rival AbbVie’s Skyrizi: BNP Paribas - Seeking Alpha
AbbVie (ABBV) slides as investors weigh policy-related pricing risk and recent financing activity - Quiver Quantitative
What triggered AbbVie shares' latest price pullback - Traders Union
AbbVie, Philip Morris among market cap stock movers on Wednesday - Investing.com
Weak momentum, oversold signals: AbbVie stock slides 3.70% - Traders Union
AbbVie Inc Stock (ABBV) Moved Down by 4.60% on Mar 18: A Full Analysis - TradingKey
AbbVie Stock: EPS Set to Jump 45% in 2026 as Skyrizi and Rinvoq Dominate IBD - TIKR.com
AbbVie Inc. $ABBV Shares Sold by Wilmington Savings Fund Society FSB - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Sunbelt Securities Inc. - MarketBeat
Danske Bank A S Invests $279.61 Million in AbbVie Inc. $ABBV - MarketBeat
Livforsakringsbolaget Skandia Omsesidigt Has $31.89 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Captrust Financial Advisors Boosts Position in AbbVie Inc. $ABBV - MarketBeat
Abbvie Inc Stock (ABBV) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):